Talkspace (TALK) Competitors

$3.12
+0.04 (+1.30%)
(As of 04/26/2024 ET)

TALK vs. INNV, PNTG, DCGO, WGS, SHCR, PIII, USPH, IRMD, PHAT, and EXAI

Should you be buying Talkspace stock or one of its competitors? The main competitors of Talkspace include InnovAge (INNV), The Pennant Group (PNTG), DocGo (DCGO), GeneDx (WGS), Sharecare (SHCR), P3 Health Partners (PIII), U.S. Physical Therapy (USPH), Iradimed (IRMD), Phathom Pharmaceuticals (PHAT), and Exscientia (EXAI). These companies are all part of the "medical" sector.

Talkspace vs.

Talkspace (NASDAQ:TALK) and InnovAge (NASDAQ:INNV) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, community ranking, valuation, risk, profitability, institutional ownership, media sentiment, earnings and dividends.

InnovAge has a net margin of -4.38% compared to Talkspace's net margin of -12.78%. InnovAge's return on equity of -10.53% beat Talkspace's return on equity.

Company Net Margins Return on Equity Return on Assets
Talkspace-12.78% -16.06% -13.51%
InnovAge -4.38%-10.53%-5.69%

Talkspace currently has a consensus target price of $3.00, indicating a potential downside of 3.85%. InnovAge has a consensus target price of $6.50, indicating a potential upside of 66.24%. Given InnovAge's higher possible upside, analysts clearly believe InnovAge is more favorable than Talkspace.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Talkspace
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
InnovAge
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

57.4% of Talkspace shares are held by institutional investors. Comparatively, 12.3% of InnovAge shares are held by institutional investors. 18.4% of Talkspace shares are held by insiders. Comparatively, 0.4% of InnovAge shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Talkspace has a beta of 1.26, suggesting that its share price is 26% more volatile than the S&P 500. Comparatively, InnovAge has a beta of 0.15, suggesting that its share price is 85% less volatile than the S&P 500.

Talkspace and InnovAge both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
TalkspaceOutperform Votes
No Votes
Underperform Votes
3
100.00%
InnovAgeOutperform Votes
No Votes
Underperform Votes
3
100.00%

Talkspace has higher earnings, but lower revenue than InnovAge. Talkspace is trading at a lower price-to-earnings ratio than InnovAge, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Talkspace$150.04M3.51-$19.18M-$0.12-26.00
InnovAge$688.09M0.77-$40.67M-$0.25-15.64

In the previous week, Talkspace and Talkspace both had 8 articles in the media. Talkspace's average media sentiment score of 0.31 beat InnovAge's score of 0.01 indicating that Talkspace is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Talkspace
2 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
InnovAge
2 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Talkspace beats InnovAge on 7 of the 13 factors compared between the two stocks.

Get Talkspace News Delivered to You Automatically

Sign up to receive the latest news and ratings for TALK and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TALK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TALK vs. The Competition

MetricTalkspaceHealth services IndustryMedical SectorNASDAQ Exchange
Market Cap$526.97M$818.54M$4.88B$7.56B
Dividend YieldN/A1.75%2.92%3.95%
P/E Ratio-26.0026.87163.7515.44
Price / Sales3.512.172,352.3785.90
Price / CashN/A19.1846.6234.73
Price / Book4.392.174.764.33
Net Income-$19.18M-$15.00M$103.28M$214.22M
7 Day Performance-0.64%-0.18%0.74%1.88%
1 Month Performance-12.61%-7.99%-7.56%-5.23%
1 Year Performance285.19%3.08%9.15%8.41%

Talkspace Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
INNV
InnovAge
0.8479 of 5 stars
$4.00
-0.7%
$6.50
+62.5%
N/A$543.60M$688.09M-16.002,100News Coverage
PNTG
The Pennant Group
1.6811 of 5 stars
$21.42
+2.7%
$18.75
-12.5%
+51.2%$650.95M$544.89M48.685,791Upcoming Earnings
DCGO
DocGo
4.8031 of 5 stars
$3.50
-0.3%
$10.83
+209.5%
-55.2%$364.60M$624.29M50.004,164Short Interest ↓
WGS
GeneDx
2.1417 of 5 stars
$12.00
+15.5%
$13.00
+8.3%
+17.5%$312.60M$202.57M-1.611,000Upcoming Earnings
SHCR
Sharecare
0.9984 of 5 stars
$0.73
+4.3%
$1.00
+36.9%
-47.4%$261.83M$445.25M-1.973,352Short Interest ↑
PIII
P3 Health Partners
1.3259 of 5 stars
$0.51
-1.9%
$4.75
+825.9%
-61.2%$162.06M$1.27B-0.79400Positive News
USPH
U.S. Physical Therapy
3.5003 of 5 stars
$103.51
+3.6%
$125.67
+21.4%
-4.1%$1.56B$604.80M76.676,720Upcoming Earnings
IRMD
Iradimed
4.992 of 5 stars
$41.90
-1.1%
$62.50
+49.2%
+2.4%$530.45M$65.56M30.81148Upcoming Earnings
Analyst Revision
News Coverage
PHAT
Phathom Pharmaceuticals
2.1331 of 5 stars
$9.06
+0.6%
$21.33
+135.5%
-10.1%$530.19M$680,000.00-2.34452Analyst Report
EXAI
Exscientia
1.5432 of 5 stars
$4.38
+3.1%
$9.75
+122.6%
-21.0%$529.50M$25.60M-2.96483Positive News
Gap Down

Related Companies and Tools

This page (NASDAQ:TALK) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners